Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

The Week in Review: 3SBio and Ascentage Form Cancer Partnership

publication date: Feb 13, 2010
3SBio (沈阳三生制药) and Ascentage Pharma will develop targeted cancer therapeutics focusing on programmed cell death; Allele Biotech was granted a China patent with far-reaching claims for RNAi; Private equity investors in the west currently find emerging markets, especially China, an attractive investment; Gorbec Pharm will open a GMP-compliant analytical laboratory in Yantai; NeoStem priced a public offering of 5,000,000 shares; 3SBio in-licensed the China rights to a phosphate binder for dialysis patients; Simcere Pharma (先声药业) received SFDA approval to market  the flu drug Relenza; Celsis In Vitro Technologies found a China distributor for its drug discovery products; OrbusNeich began a China clinical trial of its Genous Bio-engineered R stent; and Tianyin Pharma reported positive results for its fiscal Q2. More details...

Stock Symbols: (NSDQ: SSRX) (NYSE Amex: NBS) (NYSE: SCR) (NYSE Alternext: TPI)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital